Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
International Journal of Geriatric Psychiatry
|
January 14, 1998
Time course of response to ECT
J Laidlaw, P Bentham
BMJ (Clinical Research Ed.)
|
September 3, 1999
Effectiveness of rivastigmine in Alzheimer's disease. Improvements in functional ability remain unestablished
P Bentham, R Gray, E Sellwood, et al.
The Cochrane Database of Systematic Reviews
|
February 20, 2004
Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse
E Day, P Bentham, R Callaghan, et al.
Developmental Medicine and Child Neurology
|
January 5, 2000
Catatonia, autism, and ECT
F K Zaw, G D Bates, V Murali, et al.
Medical Care
|
July 27, 2001
EQ-5D in patients with dementia: an investigation of inter-rater agreement
W Coucill, S Bryan, P Bentham, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
March 26, 2005
Proxy completion of EQ-5D in patients with dementia
S Bryan, W Hardyman, P Bentham, et al.
International Journal of Geriatric Psychiatry
|
May 29, 2001
Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type
A J Gray, V Staples, K Murren, et al.
The Lancet. Neurology
|
December 11, 2007
Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial
, P Bentham, R Gray, et al.
The Journal of Prevention of Alzheimer'S Disease
|
October 25, 2022
Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate
C M Wischik, P Bentham, S Gauthier, et al.
International Journal of Geriatric Psychiatry
|
July 10, 2008
Determinants of burden in those who care for someone with dementia
P Campbell, J Wright, J Oyebode, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
International Journal of Geriatric Psychiatry
|
January 14, 1998
Time course of response to ECT
J Laidlaw, P Bentham
BMJ (Clinical Research Ed.)
|
September 3, 1999
Effectiveness of rivastigmine in Alzheimer's disease. Improvements in functional ability remain unestablished
P Bentham, R Gray, E Sellwood, et al.
The Cochrane Database of Systematic Reviews
|
February 20, 2004
Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse
E Day, P Bentham, R Callaghan, et al.
Developmental Medicine and Child Neurology
|
January 5, 2000
Catatonia, autism, and ECT
F K Zaw, G D Bates, V Murali, et al.
Medical Care
|
July 27, 2001
EQ-5D in patients with dementia: an investigation of inter-rater agreement
W Coucill, S Bryan, P Bentham, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
March 26, 2005
Proxy completion of EQ-5D in patients with dementia
S Bryan, W Hardyman, P Bentham, et al.
International Journal of Geriatric Psychiatry
|
May 29, 2001
Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type
A J Gray, V Staples, K Murren, et al.
The Lancet. Neurology
|
December 11, 2007
Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial
, P Bentham, R Gray, et al.
The Journal of Prevention of Alzheimer'S Disease
|
October 25, 2022
Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate
C M Wischik, P Bentham, S Gauthier, et al.
International Journal of Geriatric Psychiatry
|
July 10, 2008
Determinants of burden in those who care for someone with dementia
P Campbell, J Wright, J Oyebode, et al.
Page
of 2